Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0005686 | U2 snRNP | 5 | 1 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0071011 | precatalytic spliceosome | 4 | 1 |
GO:0097525 | spliceosomal snRNP complex | 4 | 1 |
GO:0120114 | Sm-like protein family complex | 2 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: E9AY55
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 1 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 1 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008380 | RNA splicing | 7 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.282 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.546 |
DEG_Kelch_Keap1_1 | 117 | 122 | PF01344 | 0.590 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.711 |
DOC_CKS1_1 | 11 | 16 | PF01111 | 0.497 |
DOC_CYCLIN_RxL_1 | 26 | 33 | PF00134 | 0.500 |
DOC_PP2B_PxIxI_1 | 23 | 29 | PF00149 | 0.377 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.530 |
DOC_WW_Pin1_4 | 42 | 47 | PF00397 | 0.645 |
LIG_14-3-3_CanoR_1 | 29 | 35 | PF00244 | 0.587 |
LIG_14-3-3_CterR_2 | 153 | 158 | PF00244 | 0.539 |
LIG_Actin_WH2_2 | 24 | 39 | PF00022 | 0.306 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.413 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.475 |
LIG_LIR_Gen_1 | 13 | 24 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 55 | 64 | PF02991 | 0.468 |
LIG_LIR_Gen_1 | 80 | 88 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 80 | 85 | PF02991 | 0.454 |
LIG_PDZ_Class_2 | 153 | 158 | PF00595 | 0.507 |
LIG_SH2_CRK | 16 | 20 | PF00017 | 0.417 |
LIG_SH2_STAP1 | 147 | 151 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.469 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.478 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.530 |
LIG_SUMO_SIM_par_1 | 52 | 58 | PF11976 | 0.534 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.585 |
MOD_CK2_1 | 116 | 122 | PF00069 | 0.651 |
MOD_GlcNHglycan | 119 | 122 | PF01048 | 0.589 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.303 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.517 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.259 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.574 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.559 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.518 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.456 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.465 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.621 |
MOD_PIKK_1 | 30 | 36 | PF00454 | 0.512 |
MOD_PIKK_1 | 55 | 61 | PF00454 | 0.454 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.466 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.454 |
MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.524 |
MOD_ProDKin_1 | 42 | 48 | PF00069 | 0.550 |
MOD_SUMO_rev_2 | 117 | 126 | PF00179 | 0.608 |
TRG_DiLeu_BaEn_1 | 15 | 20 | PF01217 | 0.440 |
TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.510 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.416 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.437 |
TRG_ER_diArg_1 | 69 | 72 | PF00400 | 0.479 |
TRG_Pf-PMV_PEXEL_1 | 29 | 34 | PF00026 | 0.481 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBP8 | Leptomonas seymouri | 72% | 99% |
A0A0S4J184 | Bodo saltans | 38% | 99% |
A0A1X0NSD2 | Trypanosomatidae | 55% | 98% |
A0A3R7KI07 | Trypanosoma rangeli | 51% | 100% |
A0A3S7WZQ4 | Leishmania donovani | 94% | 100% |
A4HET1 | Leishmania braziliensis | 85% | 100% |
A4I207 | Leishmania infantum | 94% | 100% |
C9ZS05 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 93% |
Q4Q9B8 | Leishmania major | 94% | 100% |
V5BUP6 | Trypanosoma cruzi | 51% | 100% |